Press release
Deadline on December 8th coming up in Lawsuit for Investors in Kenvue Inc. (NYSE: KVUE)

A Deadline is coming up on December 8, 2023 in the lawsuit for certain investors in Kenvue Inc. (NYSE: KVUE).
Investors who purchased shares of Kenvue Inc. (NYSE: KVUE) have certain options and there are strict and short deadlines running. Deadline: December 8, 2023. NYSE: KVUE stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The plaintiff alleges on behalf of purchasers of Kenvue Inc. (NYSE: KVUE) common shares, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that the Registration Statement contained false and/or misleading statements and/or failed to disclose that Kenvue faces potential headwinds as a result of confirmed concerns about the efficacy of phenylephrine, which it knew or should have known, that Kenvue did not discuss risks relating to the efficacy of phenylephrine (or "PE") in its IPO, the utility of which had been questioned since at least 2007, that while the Company disclosed risks relating to litigation, it did not disclose specific risk relating to potential litigation arising from adverse findings on the efficacy of phenylephrine, and that as a result, Defendants' public statements were materially false and misleading at all relevant times and negligently prepared.
Those who purchased shares of Kenvue Inc. (NYSE: KVUE) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Deadline on December 8th coming up in Lawsuit for Investors in Kenvue Inc. (NYSE: KVUE) here
News-ID: 3311670 • Views: …
More Releases from Shareholders Foundation

Biohaven Ltd. (NYSE: BHVN) Investor Alert: Deadline in Lawsuit on September 12, …
A deadline is coming up on September 12, 2025in the lawsuit filed for certain investors of Biohaven Ltd. (NYSE: BHVN) over alleged securities laws violations by Biohaven Ltd.
Investors who purchased shares of Biohaven Ltd. (NYSE: BHVN) have certain options and there are strict and short deadlines running. Deadline: September 12, 2025. NYSE: BHVN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the…

Investigation announced for Long-Term Investors in shares of West Pharmaceutical …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of West Pharmaceutical Services, Inc..
Investors who are current long term investors in West Pharmaceutical Services, Inc. (NYSE: WST) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in (NYSE: WST stocks follows a lawsuit filed…

Investigation announced for Long-Term Investors in Open Lending Corporation (NAS …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Open Lending Corporation.
Investors who are current long term investors in Open Lending Corporation (NASDAQ: LPRO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: LPRO stocks follows a lawsuit filed against Open…

Investigation announced for Long-Term Investors in shares in BigBear.ai Holdings …
An investigation on behalf of current long-term investors in shares of BigBear.ai Holdings, Inc. (NYSE: BBAI) concerning potential breaches of fiduciary duties by certain directors and officers of BigBear.ai Holdings, Inc. was announced.
Investors who are current long term investors in BigBear.ai Holdings, Inc. (NYSE: BBAI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm…
More Releases for Kenvue
Oral Rinse Market Outlook (2025-2032): Growth Drivers, Innovation Trends & Emerg …
Oral Rinse Market is estimated to be valued at USD 7.25 Bn in 2025 and is expected to reach USD 12.03 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.5% from 2025 to 2032.
The Oral Rinse Market : A thorough analysis of statistics about the current as well as emerging trends offers clarity regarding the Oral Rinse Market dynamics. The report includes Porter's Five Forces to…
Pharyngitis Treatment Market: Comprehensive Analysis and Key Players | Kenvue In …
The Pharyngitis Treatment Market study by DataM Intelligence offer an in-depth analysis of the market, presenting insightful observations, statistics, historical data, and industry-validated market insights. The report delves into the competitive positioning of key companies, examining factors such as product offerings, pricing strategies, financial health, product portfolios, growth initiatives, and geographical reach.
Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: - https://datamintelligence.com/download-sample/pharyngitis-treatment-market
What is the projected…
Pharyngitis Treatment Market Booming Worldwide With Leading - Pfizer Inc., Novar …
DataM Intelligence has published a new research report on "Pharyngitis Treatment Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Free Sample Research PDF -…
Investigation announced for Long-Term Investors who lost money with shares of Ke …
An investigation was announced for current long-term investors in shares of Kenvue Inc. (NYSE: KVUE) concerning potential breaches of fiduciary duties by certain directors of Kenvue Inc.
Investors who are current long term investors in Kenvue Inc. (NYSE: KVUE) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NYSE: KVUE stocks…
Skin Cleansing Disinfectant Market In-Depth Analysis, Growth Strategies and Comp …
LOS ANGELES, United States: The report named, "Global Skin Cleansing Disinfectant Market Research Report 2024" has been added to the archive of market research studies by QY Research. The industry experts and researchers have offered reliable and precise analysis of the global Skin Cleansing Disinfectant market in view of numerous aspects such as growth factors, challenges, limitations, developments, trends, and growth opportunities. This report will surely act as a handy…
Lawsuit filed for Investors who lost money with shares of Kenvue Inc. (NYSE: KVU …
An investor, who purchased shares of Kenvue Inc. (NYSE: KVUE), filed a lawsuit over alleged violations of Federal Securities Laws by Kenvue Inc. in connection with certain allegedly false and misleading statements made in connection with the Company's May 2023 initial public offering
Investors who purchased shares of Kenvue Inc. (NYSE: KVUE) have certain options and for certain investors are short and strict deadlines running. Deadline: December 8, 2023. NYSE: KVUE…